Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Melanie Sena


Melanie Sena is community editor of Pharmaceutical Technology.

Articles
AMRI Closes Facility in NY
April 16, 2014

AMRI will close its DDS facility in Syracuse, NY.

GSK Receives FDA Approval for Tanzeum
April 16, 2014

GSK receives FDA approval of Tanzeum for adults with type 2 diabetes.

EMA Warns of Falsified Herceptin Vials
April 16, 2014

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

BASF Builds New Plant in Germany
April 16, 2014

BASF builds a new plant for specialty amines in Ludwigshafen, Germany.

Metrohm Appoints New President and CEO
April 14, 2014

Metrohm appoints Edward Colihan as president and CEO of Metrohm USA.

PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

Center for Biologics Evaluation and Research Relocates
April 11, 2014

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

PhRMA Appoints New Board Members
April 11, 2014

Ian Read, chairman and CEO of Pfizer, is elected chairman of the PhRMA.

Desktop Human Body Developed for Toxicity Testing
April 10, 2014

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
10%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here